Table 4.
Gene | Type of Mutation | Model | Disease | Therapy (Free GCs) | Reference |
---|---|---|---|---|---|
GR | T cell-specific deletion | AIA | unaltered | abrogated | [141] |
GR | myeloid cell-specific deletion | AIA | unaltered | unaltered | [141] |
GR | B cell-specific deletion | AIA | unaltered | unaltered | [141] |
GR | impaired dimerization, ubiquitous | AIA | unaltered | abrogated | [141] |
GR | deletion in immune cells | STIA | unaltered | unaltered | [143] |
GR | deletion in stromal cells | STIA | unaltered | abrogated | [143] |
GR | FLS-specific deletion, inducible | STIA | unaltered | partially abrogated | [143] |
11β-HSD1 | ubiquitous deletion | STIA | aggravated | partially abrogated | [144,147] |
AnX1 | ubiquitous deletion | STIA | unaltered | abrogated | [156] |
GILZ | ubiquitous deletion | CIA | unaltered | unaltered | [162] |
DUSP1 | ubiquitous deletion | CIA | aggravated | n.d. | [163] |